Search for Clinical Trial Results
Hemophilia B - 30 Studies Found
Status | Study |
Completed |
Study Name: Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B Condition: Hemophilia B Date: 2011-03-30 Interventions:
|
Withdrawn |
Study Name: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B Condition: Hemophilia B Date: 2013-11-14 Interventions: Biological: IB1001 Prophylaxis (during Treatment and Conti |
Completed |
Study Name: Study Evaluating rFIX; BeneFIX® in Hemophilia B Condition: Hemophilia B Date: 2004-10-04 Interventions: Drug: rFIX |
Active, not recruiting |
Study Name: Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B Condition: Hemophilia B Date: 2008-10-07 Interventions:
|
Completed |
Study Name: BAX 326 Surgery Study in Hemophilia B Patients Condition: Hemophilia B Date: 2012-01-09 Interventions: Biological: Recombinant factor IX Following a loading dose with BAX326, participants will receive BAX326 |
NOT_YET_RECRUITING |
Study Name: Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001 Condition: Hemophilia B Without Inhibitor Date: 2024-05-19 Interventions: Subjects will be dosed with single dose of KL001 at 2.5x10^12 vg/kg. |
RECRUITING |
Study Name: Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) Condition: Hemophilia B Date: 2024-05-19 Interventions: Adeno-associated viral vector carrying the FIX gene single infusion at dose 1. |
RECRUITING |
Study Name: Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs) Condition: Hemophilia B Date: 2024-05-19 Interventions: Administered as a single IV infusion. |
RECRUITING |
Study Name: A Study of SerpinPC in Participants With Hemophilia B (HemB) With Inhibitors Condition: Hemophilia B With Inhibitor Date: 2024-05-19 Interventions: Administered as SC injection. |
RECRUITING |
Study Name: An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX� in Patients With Hemophilia B Condition: Hemophilia B Date: 2024-05-19 Interventions: HEMGENIX is a gene therapy medicinal product that aims to deliver a factor IX (FIX) gene expression cassette to the liver of patients with hemophilia |